Status:
COMPLETED
Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon
Lead Sponsor:
Prof. Patrick Petignat
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-49 years
Phase:
NA
Brief Summary
In sub-Saharan Africa, cervical cancer is the leading cause of cancer death among women because of the difficulty in implementing screening programs. The main obstacles in these countries are poverty,...
Eligibility Criteria
Inclusion
- Women aged 30-49 years, able to comply with the study protocol
Exclusion
- Pregnancy
- Previous total hysterectomy
- Conditions impairing examination of the cervix
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 9 2024
Estimated Enrollment :
4473 Patients enrolled
Trial Details
Trial ID
NCT03757299
Start Date
October 1 2018
End Date
July 9 2024
Last Update
January 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Geneva
Geneva, Switzerland, 1205